Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 472

1.

Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides.

An Y, Jiang W, Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D'Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja BS.

Radiother Oncol. 2019 Feb;131:88-92. doi: 10.1016/j.radonc.2018.12.003. Epub 2018 Dec 31.

2.

A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma.

Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, Sulman EP, Lee HJ, Hagemeister FB, Oki Y, Fanale M, Smith GL.

Sci Rep. 2019 Feb 4;9(1):1322. doi: 10.1038/s41598-018-37197-z.

3.

Demonstration of on-chip quantum dot microcavity lasers in a molecularly engineered annular groove.

Chen C, Yuan J, Wan L, Chandrahalim H, Chen Z, Nishimura N, Takeda H, Yoshioka H, Liu W, Oki Y, Fan X, Li Z.

Opt Lett. 2019 Feb 1;44(3):495-498. doi: 10.1364/OL.44.000495.

PMID:
30702662
4.

High Serum Uric Acid is Highly Associated with a Reduced Left Ventricular Ejection Fraction Rather than Increased Plasma B-type Natriuretic Peptide in Patients with Cardiovascular Diseases.

Oki Y, Kawai M, Minai K, Ogawa K, Inoue Y, Morimoto S, Tanaka T, Nagoshi T, Ogawa T, Yoshimura M.

Sci Rep. 2019 Jan 24;9(1):682. doi: 10.1038/s41598-018-37053-0.

5.

Encapsulated Papillary Thyroid Tumor with Delicate Nuclear Changes and a KRAS Mutation as a Possible Novel Subtype of Borderline Tumor.

Ohba K, Mitsutake N, Matsuse M, Rogounovitch T, Nishino N, Oki Y, Goto Y, Kakudo K.

J Pathol Transl Med. 2019 Jan 14. doi: 10.4132/jptm.2018.12.07. [Epub ahead of print]

6.

Stage I non-Hodgkin lymphoma: no plateau in disease-specific survival ?

Chihara D, Oki Y, Fanale MA, Westin JR, Nastoupil LJ, Neelapu S, Fayad L, Fowler NH, Cheah CY.

Ann Hematol. 2019 Jan 8. doi: 10.1007/s00277-018-3571-7. [Epub ahead of print]

PMID:
30617643
7.

NK-Cell Lymphomas.

Chihara D, Oki Y.

Cancer Treat Res. 2019;176:163-184. doi: 10.1007/978-3-319-99716-2_8.

PMID:
30596218
8.

Radiotherapy in Patients with Mycosis Fungoides and Central Nervous System Involvement.

Jensen GL, Dabaja BS, Pinnix CC, Gunther JR, Huen A, Duvic M, Oki Y, Fanale M, Hosing C, Milgrom SA.

Case Rep Oncol. 2018 Nov 12;11(3):721-728. doi: 10.1159/000494081. eCollection 2018 Sep-Dec.

9.

Response-adapted radiation therapy for newly diagnosed primary diffuse large B-cell lymphoma of the CNS treated with methotrexate-based systemic therapy.

Sheu T, Milgrom SA, Andraos TY, Gunther JR, Chi L, Nastoupil L, Fowler N, Oki Y, Fanale MA, Fayad LE, Hagemeister F, Neelapu SS, Medeiros LJ, Hosing C, Nieto Y, Ahmed S, Alousi AM, Dabaja B, Pinnix CC.

Adv Radiat Oncol. 2018 Jul 12;3(4):639-646. doi: 10.1016/j.adro.2018.07.001. eCollection 2018 Oct-Dec.

10.

Exercise-Induced Oxygen Desaturation as a Predictive Factor for Longitudinal Decline in 6-Minute Walk Distance in Subjects With COPD.

Misu S, Kaneko M, Sakai H, Oki Y, Fujimoto Y, Ishikawa A, Ono R.

Respir Care. 2019 Feb;64(2):145-152. doi: 10.4187/respcare.06169. Epub 2018 Oct 16.

PMID:
30327337
11.

Relationship between the Functional Independence Measure and Mann Assessment of Swallowing Ability in hospitalized patients with pneumonia.

Mitani Y, Oki Y, Fujimoto Y, Yamaguchi T, Yamada Y, Yamada K, Ito T, Shiotani H, Ishikawa A.

Geriatr Gerontol Int. 2018 Dec;18(12):1620-1624. doi: 10.1111/ggi.13543. Epub 2018 Oct 5.

PMID:
30288885
12.

Outcome of patients with relapsed or refractory anaplastic large cell lymphoma who have failed brentuximab vedotin.

Chihara D, Wong S, Feldman T, Fanale MA, Sanchez L, Connors JM, Savage KJ, Oki Y.

Hematol Oncol. 2018 Sep 12. doi: 10.1002/hon.2560. [Epub ahead of print]

PMID:
30209819
13.

Using benchmarked lung radiation dose constraints to predict pneumonitis risk: Developing a nomogram for patients with mediastinal lymphoma.

Pinnix CC, Huo J, Milgrom SA, Yehia ZA, Fanale M, Oki Y, Dabaja BS, Smith GL.

Adv Radiat Oncol. 2018 Apr 24;3(3):372-381. doi: 10.1016/j.adro.2018.03.005. eCollection 2018 Jul-Sep.

14.

ABVD plus rituximab versus ABVD alone for advanced stage, high-risk classical Hodgkin lymphoma: a randomized phase 2 study.

Strati P, Fanale MA, Oki Y, Turturro F, Fayad LE, Bartlett NL, Gladstone DE, Kasamon YL, Portlock CS, Wilson WH, Goy A, Younes A, Lee HJ.

Haematologica. 2019 Feb;104(2):e65-e67. doi: 10.3324/haematol.2018.199844. Epub 2018 Sep 6. No abstract available.

15.

Comprehensive Genomic Profiling of Hodgkin Lymphoma Reveals Recurrently Mutated Genes and Increased Mutation Burden.

Liang WS, Vergilio JA, Salhia B, Huang HJ, Oki Y, Garrido-Laguna I, Park H, Westin JR, Meric-Bernstam F, Fabrizio D, Miller VA, Stephens PJ, Fanale MA, Ross JS, Janku F.

Oncologist. 2019 Feb;24(2):219-228. doi: 10.1634/theoncologist.2018-0058. Epub 2018 Aug 14.

PMID:
30108156
16.

Duvelisib, an oral dual PI3K-δ, γ inhibitor, shows clinical activity in indolent non-Hodgkin lymphoma in a phase 1 study.

Flinn IW, Patel M, Oki Y, Horwitz S, Foss FF, Allen K, Douglas M, Stern H, Sweeney J, Kharidia J, Kelly P, Kelly VM, Kahl B.

Am J Hematol. 2018 Nov;93(11):1311-1317. doi: 10.1002/ajh.25228. Epub 2018 Aug 31.

17.

Clinical Prediction Rules to Classify Types of Stroke at Prehospital Stage.

Uchida K, Yoshimura S, Hiyama N, Oki Y, Matsumoto T, Tokuda R, Yamaura I, Saito S, Takeuchi M, Shigeta K, Araki H, Morimoto T.

Stroke. 2018 Aug;49(8):1820-1827. doi: 10.1161/STROKEAHA.118.021794.

18.

Impact of histologic subtypes and treatment modality among patients with primary central nervous system lymphoma: a SEER database analysis.

Chihara D, Fowler NH, Oki Y, Fanale MA, Nastoupil LJ, Westin JR, Fayad LE, Neelapu SS, Cheah CY.

Oncotarget. 2018 Jun 22;9(48):28897-28902. doi: 10.18632/oncotarget.25622. eCollection 2018 Jun 22.

19.

Stage I Non-Hodgkin Lymphoma: difference in survival outcome by primary extranodal site of involvement.

Chihara D, Oki Y, Fanale MA, Westin JR, Nastoupil LJ, Neelapu S, Fayad L, Fowler NH, Cheah CY.

Br J Haematol. 2018 Jul 5. doi: 10.1111/bjh.15444. [Epub ahead of print] No abstract available.

PMID:
29978452
20.

Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL.

Pinnix CC, Ng AK, Dabaja BS, Milgrom SA, Gunther JR, Fuller CD, Smith GL, Abou Yehia Z, Qiao W, Wogan CF, Akhtari M, Mawlawi O, Medeiros LJ, Chuang HH, Martin-Doyle W, Armand P, LaCasce AS, Oki Y, Fanale M, Westin J, Neelapu S, Nastoupil L.

Blood Adv. 2018 Jun 12;2(11):1334-1343. doi: 10.1182/bloodadvances.2018017681.

21.

Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma.

Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Ju Lee H, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B.

Head Neck. 2018 Jun;40(6):1335. doi: 10.1002/hed.25149. Epub 2018 Feb 21. No abstract available.

PMID:
29851218
22.

MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas.

Huang W, Medeiros LJ, Lin P, Wang W, Tang G, Khoury J, Konoplev S, Yin CC, Xu J, Oki Y, Li S.

Mod Pathol. 2018 Sep;31(9):1470-1478. doi: 10.1038/s41379-018-0067-x. Epub 2018 May 21.

PMID:
29785017
23.

Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma.

Hu B, Oki Y.

Front Oncol. 2018 Apr 30;8:139. doi: 10.3389/fonc.2018.00139. eCollection 2018. Review.

24.

Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma.

Romaguera JE, Wang M, Feng L, Fayad LE, Hagemeister F, McLaughlin P, Rodriguez MA, Fanale M, Orlowski R, Kwak LW, Neelapu S, Oki Y, Pro B, Younes A, Samaniego F, Fowler N, Hartig K, Valentinetti M, Smith J, Ford P, Naig A, Medeiros LJ, Kantarjian HM, Goy A.

Cancer. 2018 Jun 15;124(12):2561-2569. doi: 10.1002/cncr.31361. Epub 2018 May 3.

PMID:
29723393
25.

Lipase-Catalyzed Dynamic Kinetic Resolution of C1 - and C2 -Symmetric Racemic Axially Chiral 2,2'-Dihydroxy-1,1'-biaryls.

Moustafa GAI, Oki Y, Akai S.

Angew Chem Int Ed Engl. 2018 Aug 6;57(32):10278-10282. doi: 10.1002/anie.201804161. Epub 2018 May 25.

PMID:
29704286
26.

Primary breast diffuse large B-cell lymphoma: treatment strategies and patterns of failure.

Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Oki Y, Fayad LE, Medeiros LJ, Dabaja BS, Nastoupil LJ.

Leuk Lymphoma. 2018 Dec;59(12):2896-2903. doi: 10.1080/10428194.2018.1460825. Epub 2018 Apr 26.

PMID:
29697005
27.

Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy.

Pinnix CC, Cella L, Andraos TY, Ayoub Z, Milgrom SA, Gunther J, Thosani S, Wogan C, Conson M, D'Avino V, Oki Y, Fanale M, Lee HJ, Neelapu S, Fayad L, Hagemeister F, Rodriguez MA, Nastoupil LJ, Nieto Y, Qiao W, Pacelli R, Dabaja B.

Int J Radiat Oncol Biol Phys. 2018 Jul 1;101(3):530-540. doi: 10.1016/j.ijrobp.2018.03.003. Epub 2018 Mar 14.

PMID:
29681481
28.

Evaluation of postprandial hypoglycemia in patients with nonalcoholic fatty liver disease by oral glucose tolerance testing and continuous glucose monitoring.

Oki Y, Ono M, Hyogo H, Ochi T, Munekage K, Nozaki Y, Hirose A, Masuda K, Mizuta H, Okamoto N, Saibara T.

Eur J Gastroenterol Hepatol. 2018 Jul;30(7):797-805. doi: 10.1097/MEG.0000000000001118.

29.

A phase I study of romidepsin and ifosfamide, carboplatin, etoposide for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma.

Strati P, Chihara D, Oki Y, Fayad LE, Fowler N, Nastoupil L, Romaguera JE, Samaniego F, Garg N, Feng L, Wesson ET, Ruben CE, Stafford MD, Nieto Y, Khouri IF, Hosing C, Horowitz SB, Kamble RT, Fanale MA.

Haematologica. 2018 Sep;103(9):e416-e418. doi: 10.3324/haematol.2018.187617. Epub 2018 Apr 5. No abstract available.

30.

Omitting cardiophrenic lymph nodes in the treatment of patients with Hodgkin lymphoma via modified involved-site radiation therapy.

Pinnix CC, Wirth A, Milgrom SA, Andraos TY, Aristophanous M, Pham M, Hancock D, Ludmir EB, Gunther JR, Fanale MA, Oki Y, Nastoupil L, Chuang HH, Mikhaeel NG, Dabaja BS.

Leuk Lymphoma. 2018 Apr 4:1-10. doi: 10.1080/10428194.2018.1452211. [Epub ahead of print]

PMID:
29616834
31.

Organic-inorganic hybrid microdisk laser with dye and silica mixed doping prepared by ink-jet printing method.

Mikami Y, Yoshioka H, Ryu S, Nishimura N, Oki Y.

Opt Express. 2018 Mar 19;26(6):7140-7147. doi: 10.1364/OE.26.007140.

PMID:
29609400
32.

New diagnostic criteria of adrenal subclinical Cushing's syndrome: opinion from the Japan Endocrine Society.

Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y, Ichijo T.

Endocr J. 2018 Apr 26;65(4):383-393. doi: 10.1507/endocrj.EJ17-0456. Epub 2018 Mar 23.

33.

Epstein-Barr virus-associated early gastric carcinoma with lymphoid stroma, accompanied with lymph node metastasis.

Namikawa T, Fujisawa K, Munekage E, Munekage M, Oki Y, Maeda H, Kitagawa H, Ueta H, Kobayashi M, Hanazaki K.

Mol Clin Oncol. 2018 Apr;8(4):561-566. doi: 10.3892/mco.2018.1567. Epub 2018 Feb 5.

34.

The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.

Chihara D, Fanale MA, Miranda RN, Noorani M, Westin JR, Nastoupil LJ, Hagemeister FB, Fayad LE, Romaguera JE, Samaniego F, Turturro F, Lee HJ, Neelapu SS, Rodriguez MA, Wang M, Fowler NH, Davis RE, Medeiros LJ, Oki Y.

PLoS One. 2018 Mar 14;13(3):e0191461. doi: 10.1371/journal.pone.0191461. eCollection 2018.

35.

Demonstration of versatile whispering-gallery micro-lasers for remote refractive index sensing.

Wan L, Chandrahalim H, Zhou J, Li Z, Chen C, Cho S, Zhang H, Mei T, Tian H, Oki Y, Nishimura N, Fan X, Guo LJ.

Opt Express. 2018 Mar 5;26(5):5800-5809. doi: 10.1364/OE.26.005800.

PMID:
29529781
36.

Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma.

Nieto Y, Thall PF, Ma J, Valdez BC, Ahmed S, Anderlini P, Popat U, Jones RB, Shpall EJ, Hosing C, Qazilbash M, Kebriaei P, Alousi A, Timmons M, Gulbis A, Myers A, Oki Y, Fanale M, Dabaja B, Pinnix C, Milgrom S, Champlin R, Andersson BS.

Biol Blood Marrow Transplant. 2018 Aug;24(8):1602-1609. doi: 10.1016/j.bbmt.2018.02.020. Epub 2018 Mar 2.

PMID:
29501779
37.

Effect of collagenase concentration on the isolation of small adipocytes from human buccal fat pad.

Tsurumachi N, Akita D, Kano K, Matsumoto T, Toriumi T, Kazama T, Oki Y, Saito-Tamura Y, Tonogi M, Shimizu N, Honda M.

J Oral Sci. 2018 Mar 24;60(1):14-23. doi: 10.2334/josnusd.16-0786. Epub 2018 Feb 26.

38.

Radiation Therapy as an Effective Salvage Strategy for Secondary CNS Lymphoma.

Milgrom SA, Pinnix CC, Chi TL, Vu TH, Gunther JR, Sheu T, Fowler N, Westin JR, Nastoupil LJ, Oki Y, Fayad LE, Neelapu S, Rodriguez MA, Hagemeister FB, Fanale MA, Lee HJ, Hosing C, Ahmed S, Nieto Y, Shpall EJ, Dabaja BS.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1146-1154. doi: 10.1016/j.ijrobp.2018.01.003. Epub 2018 Jan 6.

PMID:
29452771
39.

NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.

Horwitz SM, Ansell SM, Ai WZ, Barnes J, Barta SK, Choi M, Clemens MW, Dogan A, Greer JP, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Kim YH, Lunning MA, Mehta A, Mehta-Shah N, Oki Y, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shustov A, Sokol L, Torka P, Wilcox R, William B, Zain J, Dwyer MA, Sundar H.

J Natl Compr Canc Netw. 2018 Feb;16(2):123-135. doi: 10.6004/jnccn.2018.0007.

PMID:
29439173
40.

The Mechanism of Negative Transcriptional Regulation by Thyroid Hormone: Lessons From the Thyrotropin β Subunit Gene.

Sasaki S, Matsushita A, Kuroda G, Nakamura HM, Oki Y, Suda T.

Vitam Horm. 2018;106:97-127. doi: 10.1016/bs.vh.2017.06.006. Epub 2017 Aug 18. Review.

PMID:
29407449
41.

Central Nervous System Involvement in Peripheral T Cell Lymphoma.

Chihara D, Oki Y.

Curr Hematol Malig Rep. 2018 Feb;13(1):1-6. doi: 10.1007/s11899-018-0431-4. Review.

PMID:
29374824
42.

Effects of edge inclination angles on whispering-gallery modes in printable wedge microdisk lasers.

Chen C, Wan L, Chandrahalim H, Zhou J, Zhang H, Cho S, Mei T, Yoshioka H, Tian H, Nishimura N, Fan X, Guo LJ, Oki Y.

Opt Express. 2018 Jan 8;26(1):233-241. doi: 10.1364/OE.26.000233.

PMID:
29328300
43.

Novel Development of Phosphate Treated Porous Hydroxyapatite.

Doi K, Abe Y, Kobatake R, Okazaki Y, Oki Y, Naito Y, Prananingrum W, Tsuga K.

Materials (Basel). 2017 Dec 8;10(12). pii: E1405. doi: 10.3390/ma10121405.

44.

Management of Advanced and Relapsed/Refractory Extranodal Natural Killer T-Cell Lymphoma: An Analysis of Stem Cell Transplantation and Chemotherapy Outcomes.

Brammer JE, Chihara D, Poon LM, Caimi P, de Lima M, Ledesma C, Rondon G, Ciurea SO, Nieto Y, Fanale M, Dabaja B, Maziarz RT, Champlin RE, Hosing C, Oki Y.

Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e41-e50. doi: 10.1016/j.clml.2017.10.001. Epub 2017 Oct 12.

PMID:
29277360
45.

Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma.

Reddy JP, Hernandez M, Gunther JR, Dabaja BS, Martin GV, Jiang W, Akhtari M, Allen PK, Atkinson BJ, Smith GL, Pinnix CC, Milgrom SA, Abou Yehia Z, Osborne EM, Oki Y, Lee H, Hagemeister F, Fanale MA.

Br J Haematol. 2018 Feb;180(4):545-549. doi: 10.1111/bjh.15054. Epub 2017 Dec 21.

PMID:
29271057
46.

Activity of the PI3K-δ,γ inhibitor duvelisib in a phase 1 trial and preclinical models of T-cell lymphoma.

Horwitz SM, Koch R, Porcu P, Oki Y, Moskowitz A, Perez M, Myskowski P, Officer A, Jaffe JD, Morrow SN, Allen K, Douglas M, Stern H, Sweeney J, Kelly P, Kelly V, Aster JC, Weaver D, Foss FM, Weinstock DM.

Blood. 2018 Feb 22;131(8):888-898. doi: 10.1182/blood-2017-08-802470. Epub 2017 Dec 12.

PMID:
29233821
47.

Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.

Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group.

N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. Erratum in: N Engl J Med. 2018 Mar 1;378(9):878.

48.

Long-Term Remissions of Patients With Follicular Lymphoma Grade 3 Treated With R-CHOP.

Strati P, Fowler N, Pina-Oviedo S, Medeiros LJ, Overman MJ, Romaguera JE, Nastoupil L, Wang M, Hagemeister FB, Rodriguez A, Oki Y, Westin J, Turturro F, Neelapu SS, Fayad L.

Clin Lymphoma Myeloma Leuk. 2018 Jan;18(1):e103-e108. doi: 10.1016/j.clml.2017.11.001. Epub 2017 Nov 14.

PMID:
29196178
49.

Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignancies.

Flinn IW, O'Brien S, Kahl B, Patel M, Oki Y, Foss FF, Porcu P, Jones J, Burger JA, Jain N, Kelly VM, Allen K, Douglas M, Sweeney J, Kelly P, Horwitz S.

Blood. 2018 Feb 22;131(8):877-887. doi: 10.1182/blood-2017-05-786566. Epub 2017 Nov 30.

PMID:
29191916
50.

Diffuse large B-cell lymphoma in very elderly patients over 80 years old: Incorporating consolidative radiation therapy into management decisions.

Pinnix CC, Andraos TY, Dabaja B, Milgrom S, Smith G, Chihara D, Ng A, Fayad LE, Oki Y, Neelapu S, Westin J, Rodriguez MA, Nastoupil LJ.

Adv Radiat Oncol. 2017 Apr 22;2(3):370-380. doi: 10.1016/j.adro.2017.04.004. eCollection 2017 Jul-Sep.

Supplemental Content

Support Center